TB PRACTECAL

Partners: Médecins Sans Frontières (MSF) Amsterdam Office

Background:

TB PRACTECAL is a multi-center, open-label, multi-arm, randomized, controlled, Phase 2/3 trial evaluating short treatment regimens containing bedaquiline and pretomanid in combination with existing and re-purposed anti-TB drugs for the treatment of biologically confirmed pulmonary multi-drug resistant TB (MDR-TB).

Phase 3

Trial Components